Clinical study to compare the therapeutic effects of two ointments with active substances betamethasone dipropionate and salicylic acid and of one ointment without active substances for patients with chronic stable plaque poriasis
20-01/BetaSal-S
Phase 3 other active
Quick answer
Clinical study to compare the therapeutic effects of two ointments with active substances betamethasone dipropionate and salicylic acid and of one ointment without active substances for patients with chronic stable plaque poriasis for Chronic stable plaque psoriasis is a Phase 3 program (other) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharm Research Associates (UK) Limited
- Indication
- Chronic stable plaque psoriasis
- Phase
- Phase 3
- Modality
- other
- Status
- active